MedPath

Gabapentin and CRBD

Phase 3
Conditions
Postoperative Catheter-related Bladder Discomfort in Patients Undergoing open prostatectomy.
Mechanical complication of urinary (indwelling) catheter
Registration Number
IRCT2014063017811N4
Lead Sponsor
Arak University of Medical Science,Office of Vice Chancellor for Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
42
Inclusion Criteria

inclusion criteria: Patients of American Society of Anesthesiologists (ASA) physical status I-II undergoing elective open prostatectomy surgery under spinal anesthesia ; requiring catheterization of the urinary bladder ; 50–80 kg of weight
exclusion criteria: Patients with history of OAB (urinary frequency >3 times at night and > 8 times in 24 hours) ; neurogenic bladder; diabetes mellitus ; Parkinson’s disease and impaired renal function ; chronic use of opiates or sedatives ; antiacid uptake in the past 48 hours ; hypersensitivity to amide local anesthetics or gabapentin

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Catheter-related bladder discomfort(CRBD) severity. Timepoint: at hours 2,5,24,48,72 after surgery. Method of measurement: based on asking patients based on Likert scale.;Pain severity. Timepoint: at hours 2,5,24,48,72 after surgery. Method of measurement: based on VAS index.
Secondary Outcome Measures
NameTimeMethod
Total morphine requirement. Timepoint: at hours 2,6,24,48,72. Method of measurement: counting amount of morphine that will be injected to patient.;Postoperative sedation. Timepoint: at hours 2,6,24,48,72. Method of measurement: clinical examination.;Postoperative N/V. Timepoint: at hours 2,6,24,48,72. Method of measurement: clinical examination and history taking.
© Copyright 2025. All Rights Reserved by MedPath